2021 • In American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21 (11), p. 3806-3807
[en] Grupper et al. have reported on a positive humoral response post full vaccination with mRNA SARS-CoV2 BNT162b2 in only 51/136 (37.5%) kidney transplant recipients (KTRs) without prior exposure to the virus(1) . We have conducted an IRB-approved (B707201215598-2021/80) prospective small sample-size study comparing the humoral response to BNT162b2 in 40 consecutive individuals early exposed to the Belgian vaccination program, including 20 KTRs with (n=10, COVID-19(+)) versus without (n=10, COVID-19(-)) history of exposure to SARS-CoV-2 and 20 controls including 10 COVID-19(+) versus 10 COVID-19(-).
Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus [published online ahead of print April 18, 2021]. Am J Transplant. 2021. https://doi.org/10.1111/ajt.16615
Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients [published online ahead of print May 5, 2021]. JAMA. 2021;325(21):2204. https://doi.org/10.1001/jama.2021.7489.
Benotmane I, Gautier-Vargas G, Cognard N, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine [published online ahead of print April 20, 2021]. Kidney Int. 2021;99(6):1498-1500. S0085-2538[21]00389-6
Cucchiari D, Egri N, Bodro M, et al. Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients [published online ahead of print May 26, 2021]. Am J Transplant. 2021. https://doi.org/10.1111/ajt.16701
World Health Organization. Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. Updated May 12, 2021. Accessed June 9, 2021.
